We are in the first inning on both immuno-oncology and gene therapy - Jonathan Silverstein @WeathergageTeam
General Partner of OrbiMed, Jonathan Silverstein shares his views on the innovations and benefits of Life Science investing and much more at the 2016 Weathergage L.P. Annual Meeting.